Board Meeting31 Oct 2026, 01:31 pm
Advanced Enzyme Technologies Board Approves Unaudited Financial Results
AI Summary
Advanced Enzyme Technologies Ltd announced that its Board of Directors, in a meeting held on October 31, 2026, approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026. The board also analyzed requests for reclassification of promoter group members to public category shareholders under SEBI regulations. The financial results and limited review report from statutory auditors, MSK A & Associates LLP, were submitted.
Key Highlights
- Board approved unaudited financial results for Q2 FY27.
- Results cover both standalone and consolidated statements.
- Promoter reclassification requests were analyzed.
- Limited review report from auditors is enclosed.
Price Impact
More from ADVENZYMES